NEW YORK, March 7 – Sequenom has sold a MassArray system to genetic testing giant Quest Diagnostics, Sequenom said Wednesday.

Quest will use the MassArray system to identify disease-associated genetic variations and to determine susceptibility to hereditary conditions. The system has been installed at Nichols Institute, Quest's center for research and development, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.